Catalent, Novo Holdings and FTC
Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk , from acquiring contract drug manufacturer Catalent ,
Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings
The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in development of cell and gene therapies.
Unions, Public Interest Groups Call on FTC to Challenge Novo Holdings-Catalent Acquisition
Pressure has been mounting for the Federal Trade Commission to take action, with Senator Elizabeth Warren last week urging FTC Chair Lina Khan to block the merger if it violates antitrust laws.
US Unions Urge FTC to Block Novo Holdings-Catalent Deal Amid Competition Concerns
Consumer groups and labor unions have asked the FTC to block Novo Holdings' acquisition of Catalent due to competition concerns in the weight loss drug and gene therapy markets. The $16.5 billion deal could impact rivals like Amgen and Pfizer in the GLP-1 drug development field.
US Senator Warren Calls for Scrutiny of Novo Holdings' Catalent Deal
NEW YORK (Reuters) -U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo Nordisk's controlling shareholder would acquire contract drug manufacturer Catalent, saying it may give the pharmaceutical company an unlawful advantage in obesity drugs.
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could increase Novo’s dominance over the hot GLP-1 market, reducing competition and increasing prices.
Warren calls on FTC to scrutinize Novo Holdings' $16.5B Catalent buyout
As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S. Federal Trade Commission,
Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report
Financial groups and labor unions urge FTC to block Nordisk Foundation's acquisition of Catalent, citing concerns about competition and gene
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
A coalition of unions, consumer groups, and public interest organizations has written to Lina Khan, Chair of the Federal ...
devdiscourse18h
Health Headlines: Global Developments and Regulatory Moves
Current health news covers Gilead's withdrawal of a cancer drug, Texas' lawsuit against a doctor for providing ...
FierceBiotech8d
Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration
Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...
FiercePharma17h
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...